Incomplete recovery from rocuronium-induced muscle relaxation in patients with amyotrophic lateral sclerosis using sugammadex: A case report

INTRODUCTION: Patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), have higher sensitivity to nondepolarizing neuromuscular blocking agents (NMBAs) and are at higher risk for a residual block. For this reason, the use of NMBAs such as rocuronium has been limited owing to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Hea Rim, Chung, Jinhun, Kim, Nan Seol, Kim, A. Joo, Kim, Suro, Kang, Kyu Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220140/
https://www.ncbi.nlm.nih.gov/pubmed/32011508
http://dx.doi.org/10.1097/MD.0000000000018867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220140/
https://www.ncbi.nlm.nih.gov/pubmed/32011508
http://dx.doi.org/10.1097/MD.0000000000018867

Ejemplares similares